NewsIraq approves Sinopharm, AstraZeneca COVID-19 vaccines for emergency use

Iraq approves Sinopharm, AstraZeneca COVID-19 vaccines for emergency use

-

Cairo (Egypt): The Iraqi authorities have approved the coronavirus vaccines by UK-Swedish company AstraZeneca and China’s Sinopharm for emergency use, the Iraqi Ministry of Health said on Tuesday.

“The National Authority for Drug Selection has approved vaccines by the UK’s AstraZeneca and China’s Sinopharm for emergency use to fight the coronavirus pandemic,” the ministry said in an official statement.

In late December, the Iraqi drug authority granted an emergency vaccination with the Pfizer/BioNTech vaccine. Following that, the director-general of public health at the health ministry said that Baghdad plans to receive the first batch of the vaccine against COVID-19 sometime in February, as the country has secured a preliminary import deal for 1.5 million doses of the Pfizer vaccine.

As of now, the Iraqi health officials have registered 609,029 COVID-19 cases since the start of the pandemic, including 12,953 deaths.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Swiss unanimously votes for same-sex union referendum

GENEVA — In Switzerland, a controversial same-sex marriage referendum has been resoundingly approved by voters of the conservative, rich Alpine...

New Covid surge overwhelms hospitals in parts of US

WASHINGTON, D.C. — According to one of the country's top health officials, the spike in coronavirus cases in the...

China wants effeminate male celebs to man up

WASHINGTON — Macho men are in and effeminate male performers are out as Beijing expands its crackdown on China's entertainment...

Billie Eilish, BTS to perform at climate change concert

Billie Eilish, BTS, and Elton John, among others, will donate their star power to Global Citizen Live on Saturday...

Google faces off EU in court over record $5.1 billion antitrust fine

This week, Google will face the European Commission in a five-day court hearing, appealing a record $5.1 billion fine...

WHO’s Covax misses 2021 target. What went wrong?

The latest supply forecast for Covax – the programme for sharing COVID-19 vaccines around the world – suggests that accelerating vaccination...

Must read

You might also likeRELATED
Recommended to you